NO20040866L - Ny oral forlenget frigivelses doseringsform - Google Patents

Ny oral forlenget frigivelses doseringsform

Info

Publication number
NO20040866L
NO20040866L NO20040866A NO20040866A NO20040866L NO 20040866 L NO20040866 L NO 20040866L NO 20040866 A NO20040866 A NO 20040866A NO 20040866 A NO20040866 A NO 20040866A NO 20040866 L NO20040866 L NO 20040866L
Authority
NO
Norway
Prior art keywords
dosage form
release dosage
oral extended
new oral
new
Prior art date
Application number
NO20040866A
Other languages
English (en)
Inventor
Karin Ellstrom
Ulf Kjellberg
Annika Schweighofer
Maritta Temsamani
Original Assignee
Astrazeneca Ab Global Ip
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab Global Ip filed Critical Astrazeneca Ab Global Ip
Publication of NO20040866L publication Critical patent/NO20040866L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12Antidiuretics, e.g. drugs for diabetes insipidus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
NO20040866A 2001-08-29 2004-02-26 Ny oral forlenget frigivelses doseringsform NO20040866L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0102886A SE0102886D0 (sv) 2001-08-29 2001-08-29 New formulation
PCT/SE2002/001540 WO2003017982A1 (en) 2001-08-29 2002-08-28 A new extended release oral dosage form

Publications (1)

Publication Number Publication Date
NO20040866L true NO20040866L (no) 2004-04-19

Family

ID=20285177

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040866A NO20040866L (no) 2001-08-29 2004-02-26 Ny oral forlenget frigivelses doseringsform

Country Status (15)

Country Link
US (1) US20040204482A1 (no)
EP (1) EP1423098A1 (no)
JP (1) JP2005504051A (no)
KR (1) KR20040032976A (no)
CN (1) CN1547466A (no)
BR (1) BR0212166A (no)
CA (1) CA2457339A1 (no)
HU (1) HUP0401587A3 (no)
IL (1) IL160372A0 (no)
MX (1) MXPA04001812A (no)
NO (1) NO20040866L (no)
NZ (1) NZ531437A (no)
SE (1) SE0102886D0 (no)
WO (1) WO2003017982A1 (no)
ZA (1) ZA200401085B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0302824D0 (sv) * 2003-10-24 2003-10-24 Astrazeneca Ab New use
CN103140243A (zh) * 2010-08-09 2013-06-05 迪格玛斯玛特有限公司 益生菌液体食品

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
US4837032A (en) * 1986-02-04 1989-06-06 Farval Ag Theophylline sustained release tablet
GB8624213D0 (en) * 1986-10-09 1986-11-12 Sandoz Canada Inc Sustained release pharmaceutical compositions
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
SE510305C2 (sv) * 1997-05-30 1999-05-10 Astra Ab Nytt salt
AR035642A1 (es) * 2000-05-26 2004-06-23 Pharmacia Corp Uso de una composicion de celecoxib para el alivio rapido del dolor

Also Published As

Publication number Publication date
CA2457339A1 (en) 2003-03-06
NZ531437A (en) 2005-12-23
ZA200401085B (en) 2005-06-22
BR0212166A (pt) 2004-07-13
HUP0401587A3 (en) 2007-03-28
WO2003017982A1 (en) 2003-03-06
MXPA04001812A (es) 2004-07-08
IL160372A0 (en) 2004-07-25
US20040204482A1 (en) 2004-10-14
CN1547466A (zh) 2004-11-17
KR20040032976A (ko) 2004-04-17
EP1423098A1 (en) 2004-06-02
SE0102886D0 (sv) 2001-08-29
HUP0401587A2 (hu) 2004-11-29
JP2005504051A (ja) 2005-02-10

Similar Documents

Publication Publication Date Title
ATE296619T1 (de) Feste orale dosierungsform von simethicon
NO20025450L (no) Ny farmasöytisk sammensetning
IS6686A (is) Hýdrógel-drifið lyfjaskömmtunarform
DK1432329T3 (da) Tandbörste
DK1199054T3 (da) Væskefrakturhånddel
ATE513491T1 (de) Zahnbürste
NO20030713D0 (no) Oral faststoffdose vaksine
EE200300416A (et) Ravimvorm
ATE285752T1 (de) Inhalationskapseln
UY3265Q (es) Cepillo dental
NO20035121D0 (no) Ny anvendelse
DE60037282D1 (de) Zahnpflegemittel
DE60214455D1 (de) Dentale Reibahle
NO20033205D0 (no) Terapeutiske kromanforbindelser
DE50209245D1 (de) Neuroprotektives medikament
DE60225985D1 (de) Dentaleinheit
NO20040857L (no) Ny oral forlenget frigivelses doseringsform.
DE60210813D1 (de) Zahnbürste
NO20033919D0 (no) Ny anvendelse
NO20040866L (no) Ny oral forlenget frigivelses doseringsform
DE60212324D1 (de) Dentalmaterial
FI20012242A0 (fi) Uudet farmaseuttiset yhdisteet
NO20033586D0 (no) Tannbörste
UY3284Q (es) Cepillo dental
UY3338Q (es) Cepillo dental

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application